Inicio > Medicina Interna > Capsaicina y su uso en neuropatía diabética > Página 5

Capsaicina y su uso en neuropatía diabética

55. Garcia CM., Guzman F., Mora E., Buitrago G., Reyes LE., Gomez A. Capsaicina intravesical: una alternativa en pacientes con vejiga hiperactiva idiopática de difícil manejo. RevistaMed. 2005

56. Chhabra N., Aseri ML., Goyal V., Sankhla S. Capsaicin: Apromising therapy. A critical reapprisal. Inter.Jou.Nut: Vol. 2, Issue 1,2012: 8-15 ,

57. Revista International Association for the Study of Pain. Published by Elsevier B.V.doi:10. 1016./j.pain. 2004. 12.010.

58. J Szolcsanyi. Forty years in capsaicin research for sensory pharmacology and physiology. Neropeptide 38. (2004) : 377-384.Elsevier

59. Tesfaye S., Boulton A., Dyck P., Freeman R., Kempler P.,Lauria G.,Malik R., Spallone V., Vinik A., Bernardi L., Valensi P., Diabetic Neuropathies: Update on definitios, diagnostic criteria, estimation of severity and treatments .Diabets Care, Volune 33, Number 10, Octuber 2010

60. Helyes Zs, A Nemeth,J Jakab, B Pinter, E Banvolgyi, A K Kereskai, J Szolcanyi. Anti-inflammatory and analgesic effects of somastotatin released from capsaicin-sensitive sensory nerve terminals in Freund´s adjuvant-induced chronic arthritis model of the rat. Arthr. Rheuma. 50,1677-1685,2004.

61. T. Takanohashi,M. Isaka, K. Ubakata, R Mihara, B. Bernard. Studies of the toxicological potential of capsinoids , XIII:Inhibitory effects of capsicin and capsinoids on Cytochrome P450 in human liver microsomes.Intern.J.of Toxicol ,2010 ,29: 22S.

62. T. Kodama, T Masuyama, T Kayara, S Tsubuku , T Ohishi B Wagner, B Bernard. Studies of the toxicological potential of capsinoids , XIV: A 26-week gavage toxicity study of dihidrocapsiate in rats. Intern. J. of Toxicol, 2010 ,29: 27S.

63. B Bernaard, K Ubakata, R Mihara, Y Sato, H Nemoto .Studies of the toxicological potential of capsinoids , XI: Pharmacokinetics and tissue distribution study of 14-c dihidrocapsiate and metabolites in rats. Intern. J. of Toxicol ,2010 ,29: 3S.

64. Bernard BK, Watanabe E, Kodama T, el al. Studies of the toxicological potential of capsinoids IX: teratology studies of dihydrocapsiate in rats and rabbits. Int.J. of Toxicol. 2008; 27(suppl 3);119-136

65. Kodama T, Watanabe E, Tsubuku S, et al. Studies of the toxicological potential of capsinoids, VII. A 13-week gavage toxicity study of dihydrocapsiate in rats. Int. J. of Toxicol. 2008; 27(suppl 3);79-100

66. Watanabe E, Kodama T, Masuyama T, Tsubuku S ,Nakajima M, Bernard B. Studies of the potential of capsinoids: VI. Single-Dose toxicity study and micronucleus test of commercial-grade dihydrocapsiate Int.J.of Toxicol. 2008; 27;73-76.

67. Macho A, Calzado M, Muñoz-Blanco J, Gomez-Diaz C, Gajate C, Mollineido F, Navas P, Muñoz E. Selective induction of apoptosis in transformed cells: the role of recative oxygen and calcium.Cell death and Differentation (6) : 1999; 155-165.http://www.stockton-press.co.uk/cdd

68. Cameron NE, Cotter MA. The relationship of vascular changes to metabolic factors in diabetes mellitus and their role in the development of peripheral nerve complications. Diab metab Rev 10 :1994: 189-224

69. Quatraro A, Roca P, Donzella C, Acampora R, Marfella R, Giugliano D.Acetyl-l-carnitine for symptomatica diabetic neuropathy. Diabetologia 38: 1995: 123

70. Suziki YJ, Tsuchiya M, Packer L. Thiocitic acid and dihydrolipoic acid are novel antioxidants wich interact with reactive oxygen species.Free Rad Res Comms 15:1991:255-263

71. Bode A,Dong Z.The two faces of capsaicin .American Association for Cancer Research. Cancer Res 2011;2809-2814